- KALA BIO Inc at HC Wainwright Ophthalmology Virtual Conference - Pre Recorded TranscriptAug 16, 2023
- Kala Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q2 2022 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2022€14.06 (+2.37%)Earnings
- Q1 2022 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 16, 2022€35.43 (+16.05%)Earnings
- Q4 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptMar 29, 2022€66.8 (-15.92%)Earnings
- Q3 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 15, 2021€93.63 (+1.88%)Earnings
- Q2 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021€124.55 (-13.63%)Earnings
- Kala Pharmaceuticals Inc at BofA Securities 2021 Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2021€252.9 (-6.47%)Earnings
- Q4 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptFeb 25, 2021€337.5 (-8.78%)Earnings
- Kala Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2020€305 (-0.81%)Earnings
- Kala Pharmaceuticals, Inc. - Special Call TranscriptOct 27, 2020
- Kala Pharmaceuticals, Inc. - Special Call TranscriptSep 17, 2020
- Q2 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2020€387.5 (+1.31%)Earnings
- Kala Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 25, 2020
- Kala Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 13, 2020
- Q1 2020 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2020€535 (+7.00%)Earnings
- Kala Pharmaceuticals Inc STRIDE 3 Data Conference Call TranscriptMar 09, 2020
- Q4 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptFeb 12, 2020€292.5Earnings
- Kala Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2019€158 (-4.24%)Earnings
- Q2 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019€222.53 (-9.02%)Earnings
- Kala Pharmaceuticals Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Kala Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2019€314.05 (-3.72%)Earnings
- Q4 2018 Kala Pharmaceuticals Inc Earnings Call TranscriptMar 11, 2019Earnings
Kala Pharmaceuticals, Inc. - Special Call Transcript
Good morning, and welcome to Kala Pharmaceuticals' EYSUVIS FDA approved conference call. Please be advised that today's conference call is being recorded. (Operator Instructions)
I would now like to turn the call over to Niranjan Kameswaran, Senior Vice President of Strategy for Kala Pharmaceuticals. Please proceed.
Thank you, operator. Good morning, everyone. Welcome to our conference call to discuss the FDA approval of EYSUVIS. You can access our press release announcing the approval by going to the Investors section of our website at Kalarx.com. With me on today's call are: Mark Iwicki, Chairman, President and Chief Executive Officer; Todd Bazemore, Chief Operating Officer; Mary Reumuth, Chief Financial Officer; Kim Brazzell, Chief Medical Officer; and Hongming Chen, Chief Scientific Officer.
Before we begin, I would like to caution that comments made by management during this conference call about Kala's future expectations, plans and prospects are forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)